The APPA promotes healthcare market research services in Asia globally, with Krea’s admission strengthening the alliance’s presence in India.

Through the APPA framework, pharmaceutical companies, healthcare consultancies and market research organisations can gain access to integrated project management capabilities and guidance through local regulations.

The alliance also seeks to address regional disparities in healthcare infrastructure and offer clients access to healthcare professional insights.

Holden Healthcare currently operates across 14 Asian markets, with Krea focused on India’s healthcare market research industry.

Jeffrey Kelsch, managing partner at Holden Healthcare, said: “APPA’s expansion with Krea marks another transformative moment in Asian healthcare market research.

“This collaboration strengthens our capabilities in one of Asia’s most vital healthcare markets and demonstrates our commitment to providing comprehensive coverage across the region.”

Pravin Shekar, chief executive officer at Krea, added: “Joining APPA aligns with our vision of delivering precision health insights.

“This alliance creates unprecedented opportunities for accessing comprehensive healthcare insights across Asia, while maintaining the highest quality standards in research delivery.”